WebTreatment of lung disease: For patients with scleroderma who have rapidly worsening pulmonary fibrosis (scarring of the lung tissue), the drug cyclophosphamide (Cytoxan®) - a form of chemotherapy - has been proven to be useful in a recent NIH study. WebFeb 2, 2024 · Scleroderma renal crisis is a rare but severe complication of SS that remains a significant risk factor for the life threatening progression of the disease. ... such as methotrexate or Cytoxan ...
Cytoxan Chemotherapy for MS Treatment: Uses & Side Effects
WebNov 8, 2024 · Short-course, low-dose Cytoxan is commonly used by doctors to treat autoimmune diseases and has emerged as the current standard of care for the treatment of scleroderma. A variety of medical reports suggest that high-dose Cytoxan is beneficial in patients with severe scleroderma and particularly effective in slowing down damage in … WebSCOT is a clinical research study designed for people with severe forms of scleroderma. SCOT stands for Scleroderma: Cyclophosphamide Or Transplantation. The SCOT … img off road
Is there still a role for cyclophosphamide in the treatment …
WebFeb 12, 2024 · Objective To compare safety and efficacy outcomes between the cyclophosphamide (CYC) arms of Scleroderma Lung Study (SLS) I and II. Methods Participants enrolled in the CYC arms of SLS I (n = 79) and II (n = 69) were included. SLS I and II randomized participants to oral CYC for 1 year and followed patients for an … WebThe initial results of this study were released in November 2016 (Assassi et al. 2016). At that point a total of 75 patients with diagnosed diffuse systemic scleroderma and high-risk lung and/or renal involvement were randomized to receive either 12 monthly cyclophosphamide (Cytoxan) treatments or HSCT. Patients were followed for 54 months. WebFeb 12, 2024 · Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II Elizabeth R. Volkmann , Donald P. … im goi8ng to give viov a kid and her furure